Study suggesting new risk factor could influence NICE guidance
GSK’s orphan drug approved to treat reduced platelet count in patients with a rare blood disorder
Eugene Pozniak examines the changing face of Continuing Medical Education
Featured Appointment
Dr Michael Capaldi has joined Scottish life sciences research hub Edinburgh BioQuarter as director of commercialisation.
He will lead a...
Service Company News
Service Search
Featured Event
27/04/2010 - 29/04/2010 -
Barcelona,










